Epigenome breakthrough

  • February 6, 2014
Epigenome breakthrough

A new computational method which can identify changes in the epigenome across human populations that are associated with diseases such as arthritis has been developed by Gates Cambridge Alumnus James Zou.

A new computational method which can identify changes in the epigenome across human populations that are associated with diseases such as arthritis has been developed by a Gates Cambridge Scholar.

James Zou leads a study on the method which has just been published in Nature Methods.

There has been a lot of interest in finding genetic mutations associated with diseases, but finding epigenetic changes has been challenging up until now.

It is well known that genetic changes, i.e. mutations to DNA, can increase or decrease our risk for a variety of diseases. However, increasing interest is now focusing on how epigenetic changes – changes in the 3D packaging of DNA inside the cell and which part of the genome is accessible – can also be a significant driver for many diseases, including many forms of cancer.

The standard way to identify genetic mutations is to compare the genomes of people with a disease and healthy people to see which mutations are specific to the patients. However, it is very difficult to use this approach to identify epigenetic changes since different cells in the human body have very different epigenomes.

When the epigenome of an individual is measured, a heterogeneous sample of cells is used. So most of the differences highlighted in the epigenomes are due to the fact that samples from different individuals contain different mixtures of cells. This gives rise to many false signals and makes it difficult to identify the true epigenetic changes associated with disease.

The new research proposes a method, FaST-LMM-EWASher, that automatically corrects for cell-type composition without the need for explicit knowledge of it. It was done in collaboration with scientists at Microsoft Research.

James [2007], who did Part III Applied Mathematics at Cambridge, says: “The algorithm we developed for the paper solves this problem by modelling the heterogeneity of samples.”

James is currently a research fellow at the Simons Institute for the Theory of Computing at UC Berkeley. He says some of the mathematical techniques he learnt at Cambridge were essential for developing the algorithm.

Picture credit: www.freedigitalphotos.net and Photokanok.

 

 

Latest News

Cambridge event for new book by leading thinkers

Artificial intelligence gets a lot of bad press, but if harnessed correctly has the ability to create jobs and drive growth through enhancing productivity and helping countries level up, according to a new book by some of the world’s leading thinkers. The book, Permacrisis: A Plan to Fix a Fractured World, explores pressing global issues […]

Rainforest carbon credit schemes less effective than thought, claims report

The effectiveness of widely used rainforest carbon credit schemes has been called into question by a new study. The study, Reducing Emissions from Deforestation and Forest Degradation (REDD+) Carbon Crediting,  by the Berkeley Carbon Trading Project is co-authored by Gates Cambridge Scholar Libby Blanchard [2012] and has been making headlines around the world. It brings […]

Gates Cambridge Trust seeks Global Engagement Officer

About us  Gates Cambridge Scholarships are prestigious, highly competitive, full-cost scholarships awarded to outstanding applicants from countries outside the UK to pursue a full-time postgraduate degree in any subject available at the University of Cambridge. Gates Cambridge Scholars become part of a lifelong global community defined by its core value of commitment to improving the […]

How combining clinical data could improve traumatic brain injury outcomes

Researchers, led by a Gates Cambridge Scholar, have integrated all medical data collected from traumatic brain injury (TBI) patients to calculate, for the first time, the personalised contribution of each clinical event to long-term recovery. This international effort marks a step towards patient-centred treatment in the intensive care unit (ICU). Shubhayu Bhattacharyay [2020] is the lead […]